Necrotizing eosinophilic granulomatous lymphadenitis with ring- and C-shaped granulomas—an underrecognized specific manifestation of nodal Churg-Strauss syndrome
Tóm tắt
Từ khóa
Tài liệu tham khảo
Chumbley LC, Harrison EG Jr, De Remee RE (1977) Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Mayo Clin Proc 52:477–484
Sinico RA, Di Toma L, Maggiore U et al (2006) Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis 47:770–779
Churg A (2001) Recent advances in the diagnosis of Churg-Strauss syndrome. Mod Pathol 14(12):1284–1293
Cualing H, Schroder L, Perme C (2001) Allergic granulomatosis secondary to a limited form of Churg-Strauss syndrome—a case report with histologic and Immunophenotypic analysis. Arch Pathol Lab Med 125:954–957
Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitis. Arthritis Rheum 65(1):1–11
Scott DGI, Watts RA (2000) Systemic vasculitis: epidemiology, classification and environmental factors. Ann Rheum Dis 59:161–163
Churg J, Strauss L (1951) Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol 27:277–301
Clabrese LH, Edworthy SM, Fauci AS et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome. Arthritis Rheum 33:1094–1100
Choi JY, Kim JE, Choi IY, et al (2016) Churg-Strauss syndrome that presented with mediastinal lymphadenopathy and calculous cholecystitis Korean J Intern Med 31:179–183
Julie P. Chou JP, Kelly M, Flemons W (2009) Generalized lymphadenopathy in a non-asthmatic: an atypical presentation of Churg-Strauss syndrome. Chest 136(4_MeetingAbstracts):21Se22S
Casey M, Radel E, Ratech H (2000) Lymph node manifestations of limited Churg–Strauss syndrome. JPHO 22(5):468–471
Lesensa O, Hansmanna Y, Nersonb J, et al (2002) Severe Churg–Strauss syndrome with mediastinal lymphadenopathy treated with interferon therapy Eur J Int Med 13:458–462
Yamamoto M, Tabeya T, Naishiro Y et al (2012) Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases. Mod Rheumatol 22(3):419–425
Sato Y, Kojima M, Takata K (2009) Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman’s disease. Mod Pathol 22:589–599
Hui PK, Chan JKC, Ng CS et al (1989) Lymphadenopathy of Kimura’s disease. Am J Surg Pathol 13(3):177–186
Khan JE, Grandpeix-guyodo C, Marroun I et al (2010) Sustained response to mepolizumab in refractory Churg-Strauss syndrome. J Allergy Clin Immunol 125(1):267–270
Moosig F, Ludwig-Gross W, Herrmann K et al (2011) Targeting interleukin-5 refractory and relapsing Churg-Strauss syndrome. Ann Intern Med 155(5):341–343
Kim S, Marigowda G, Oren E et al (2010) Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome. J Allergy Clin Immunol 125(6):1336–1343
GlaxoSmithKline, National Institute of Allergy and Infectious Diseases (NIAID) (2017) A Study to investigate mepolizumab in the treatement of eosinophilic granulomatosis with polyangiitis. In: ClinicalTrials.gov [Internet] Available from: https://clinicaltrials.gov/ct2/show/NCT02020889 NLM Identifier: NCT02020889
University of Schleswig-Holstein, GlaxoSmithKline (2012) Safety and efficacy study of mepolizumab in Churg-Strauss syndrome (MEPOCHUSS). In: ClinicalTrials.gov [Internet] Available from: https://www.clinicaltrials.gov/ct2/show/NCT00716651 NLM Identifier: NCT00716651
Brigham and Women’s Hospital, GlaxoSmithKline (2017) Mepolizumab as a steroid-sparing treatment option in the Churg-Strauss syndrome (MATOCSS) In: ClinicalTrials.gov [Internet] Available from: https://www.clinicaltrials.gov/ct2/show/NCT00527566 NLM Identifier: NCT00527566